ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 176 filers reported holding ARGENX SE in Q2 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $114,051,277 | +62.4% | 231,986 | +28.7% | 0.12% | +63.9% |
| Q2 2023 | $70,250,002 | -4.7% | 180,253 | -8.9% | 0.07% | -8.9% |
| Q1 2023 | $73,719,424 | -24.3% | 197,862 | -23.0% | 0.08% | -26.9% |
| Q4 2022 | $97,369,538 | -16.0% | 257,027 | -21.7% | 0.11% | -21.7% |
| Q3 2022 | $115,879,000 | +131.5% | 328,223 | +148.4% | 0.14% | +133.9% |
| Q2 2022 | $50,063,000 | +504.5% | 132,134 | +403.1% | 0.06% | +637.5% |
| Q1 2022 | $8,282,000 | -53.7% | 26,265 | -48.6% | 0.01% | -46.7% |
| Q4 2021 | $17,907,000 | +70.3% | 51,135 | +46.8% | 0.02% | +66.7% |
| Q3 2021 | $10,517,000 | +186.4% | 34,824 | +185.5% | 0.01% | +200.0% |
| Q2 2021 | $3,672,000 | +18.5% | 12,198 | +8.4% | 0.00% | 0.0% |
| Q1 2021 | $3,100,000 | +1007.1% | 11,257 | +806.4% | 0.00% | – |
| Q2 2020 | $280,000 | -96.7% | 1,242 | -98.9% | 0.00% | -100.0% |
| Q3 2018 | $8,563,000 | +179.3% | 112,906 | +205.1% | 0.01% | +150.0% |
| Q2 2018 | $3,066,000 | – | 37,005 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |